Related Experiment Video
Updated: May 22, 2026

Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
Published on: November 4, 2025
Growth charts for individuals with Smith-Lemli-Opitz syndrome
Ryan W Y Lee1, John McGready, Sandra K Conley
1National Institutes of Health, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA. leer@kennedykrieger.org
Insights
Smith-Lemli-Opitz syndrome (SLOS) causes significant growth restriction, approximately two standard deviations below normal. This study provides the first growth charts for SLOS patients, aiding clinical management.
Area of Science:
- Genetics and Developmental Biology
- Metabolic Disorders
- Pediatric Endocrinology
Background:
- Smith-Lemli-Opitz syndrome (SLOS) is a rare genetic disorder characterized by impaired cholesterol synthesis.
- Growth restriction and neurodevelopmental issues are common in SLOS, but detailed growth parameters are poorly understood.
- Existing literature lacks specific growth charts for monitoring SLOS patients.
Purpose of the Study:
- To establish comprehensive anthropometric data for individuals with SLOS.
- To develop reference growth charts for SLOS patients.
- To improve the clinical management and research of SLOS.
Main Methods:
- Longitudinal data collection from 78 SLOS patients aged 0.1 to 16 years.
- Analysis of anthropometric measurements.
- Comparison with Centers for Disease Control (CDC) growth norms.
Main Results:
- SLOS patients exhibit significant growth restriction, averaging two standard deviations below CDC norms.
- This study presents the largest available cohort data for SLOS growth parameters.
- Novel growth charts for SLOS have been generated.
Conclusions:
- The study provides crucial growth data and reference charts for SLOS.
- These resources will aid in the diagnosis, monitoring, and management of growth in SLOS patients.
- Further research into the etiology and consequences of SLOS growth restriction is warranted.
Abstract:
Smith-Lemli-Opitz syndrome (SLOS) is a rare multiple congenital anomaly neurodevelopmental syndrome of impaired cholesterol synthesis. Growth restriction and developmental delay are very common clinical manifestations of SLOS. The degree, etiology, and consequences of growth restriction in SLOS remain an area of limited knowledge to the scientific community. There have been no studies describing the growth parameters and providing reference growth charts for individuals with SLOS. Our longitudinal data from 78 patients between the ages of 0.1 and 16 years with SLOS show a growth restriction of about two standard deviations below the Centers for Disease Control (CDC) norms for age. This study represents comprehensive anthropometric data from the largest cohort available, and proposes growth charts for widespread use in the management and study of individuals with SLOS.
More Related Videos
Related Concept Videos
Pedigree Analysis
Life Histories
Life Tables
Pleiotropy

